A Study of DF6002 Alone and in Combination With Nivolumab
Dragonfly Therapeutics
Dragonfly Therapeutics
Dragonfly Therapeutics
Immunocore Ltd
Seagen Inc.
AI Labs Group S.L
Centre Oscar Lambret
University of Rochester
BioNTech SE
Dana-Farber Cancer Institute
Emory University
McGuire Institute
Institute of Oncology Ljubljana
Endeavor Biomedicines, Inc.
Case Comprehensive Cancer Center
Hasumi International Research Foundation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Institute of Oncology Ljubljana
Pfizer
Melanoma Institute Australia
H. Lee Moffitt Cancer Center and Research Institute
Amgen
San Gallicano Dermatological Institute IRCCS
Bristol-Myers Squibb
Institute of Oncology Ljubljana
AI Labs Group S.L
AI Labs Group S.L
AI Labs Group S.L
Institute of Oncology Ljubljana
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
University Hospital, Caen
Klein Buendel, Inc.
University of Miami
Merck Sharp & Dohme LLC
Abramson Cancer Center at Penn Medicine
St. Jude Children's Research Hospital
Amgen
Adaptimmune
Hoffmann-La Roche
University of Utah
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
University of Wisconsin, Madison
Genzada Pharmaceuticals USA, Inc.
Almirall, S.A.
University of Alabama at Birmingham
CHU de Reims